Trends Report

Pharmaceutical Industry Trends Drive EA

The Impact Of Consolidation, Cost Pressures, And Networked Business Models On Pharma IT Means EA Practices Must Change

April 28th, 2009
Henry Peyret, null
Henry Peyret
With contributors:
Alex Cullen , Mimi An , Elizabeth Boehm

Summary

The pharmaceutical industry faces enormous challenges — from changes in how pharmaceutical companies develop and source products, to pricing pressures, to increasingly stringent regulatory environments. These business changes are driving IT to both reduce business costs and support new business operating models leveraging Digital Business Networks and Social Computing. As a consequence of these changes at the business and IT level, the heads of enterprise architecture (EA) within pharmas are deeply examining their EA programs and/or their priorities. The most prominent change Forrester recommends to pharmaceutical enterprise architecture programs is to endorse the concept of "next-generation EA."

Want to read the full report?

Contact us to become a client

This report is available for individual purchase ($1495).

Forrester helps business and technology leaders use customer obsession to accelerate growth. That means empowering you to put the customer at the center of everything you do: your leadership strategy, and operations. Becoming a customer-obsessed organization requires change — it requires being bold. We give business and technology leaders the confidence to put bold into action, shaping and guiding how to navigate today's unprecedented change in order to succeed.